US drug approvals
19 approvals with a product on the US market
- Cyclosporine ANDA209064 · approved 21 Jan 2026
- Klor-Con ANDA218979 · approved 28 Oct 2024
- Topiramate ANDA217694 · approved 5 Dec 2023
- Dicyclomine Hydrochloride ANDA216782 · approved 1 Jun 2023
- Diltiazem Hydrochloride ANDA217377 · approved 1 Mar 2023
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.